top of page
News, Events and Updates
Search
Anavex Life Sciences Reports Fiscal 2020 2nd Quarter Financial Results And Provides Business Updates
May 7, 2020
Anavex Life Sciences to Announce Fiscal 2020 Second Quarter Financial Results
May 4, 2020
Anavex Life Sciences Announces Publication of Clinical Data for ANAVEX®2-73 in Alzheimer's Disease
Apr 22, 2020
Anavex Life Sciences Provides Update on Clinical Program Development as Response to COVID-19
Mar 30, 2020
Anavex Life Sciences to Webcast 2020 Annual Meeting of Shareholders
Mar 22, 2020
Anavex Life Sciences Announces Foundational Data for ANAVEX®2-73 in Multiple Sclerosis (MS)
Feb 24, 2020
Anavex Life Sciences Reports Fiscal 2020 1st Quarter Financial Results
Feb 6, 2020
Anavex Life Sciences Announces Fast Track Designation Granted by US FDA for ANAVEX®2-73 Development
Feb 3, 2020
Anavex Life Sciences to Announce Fiscal 2020 First Quarter Financial Results on Thursday, 2/6/2020
Jan 30, 2020
Anavex Life Sciences Announces Achievement of Enrollment Target for ANAVEX®2-73 Phase 2 PDD Trial
Jan 27, 2020
Anavex Life Sciences Issued New US Patent for ANAVEX®2-73 Treatment of Neurodevelopmental Disorders
Jan 8, 2020
16
17
18
19
20
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
